StockData
Elite Pharmaceuticals Inc logo

Elite Pharmaceuticals Inc (ELTP) stock

ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 14/30
$0.25−0.00 (-1.37%)

Close on Oct 19, 2026Market cap $281.77MP/E 5.0Yield –

Elite Pharmaceuticals statistics

53 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
5.42%
10.8%
Shares Change (QoQ)
0.00%
0.50%
Float
1.06B
49M
Shares Held by Insiders
1.28%
11.7%
Shares Held by Institutions
0.00%
56.4%

MarginsIndustry

Gross Margin
43.7%
53.1%
Operating Margin
25.3%
-38.7%
Pretax Margin
47.8%
-11.6%
Profit Margin
41.6%
-31.6%
EBITDA Margin
26.1%
-27.7%
FCF Margin
6.02%
-9.56%

Returns on capitalIndustry

Return on Equity (ROE)
65.6%
-49.9%
Return on Assets (ROA)
46.1%
-40.6%
Return on Invested Capital (ROIC)
52.3%
-32.9%
Return on Capital Employed (ROCE)
29.1%
-37.9%

Financial positionIndustry

Current Ratio
6.65
3.30
Quick Ratio
5.40
2.39
Interest Coverage
338.18
-6.35

GrowthIndustry

Revenue Growth (YoY)
17.8%
6.82%
Net Income Growth (YoY)
333.0%
-14.4%
EPS Growth (YoY)
400.0%
-12.3%
FCF Growth (YoY)
-59.7%
6.85%
Revenue Growth (3Y CAGR)
63.3%
2.25%
Revenue Growth (5Y CAGR)
42.4%
6.41%

EfficiencyIndustry

Asset Turnover
1.11
0.40
Inventory Turnover
4.01
2.73
Revenue Per Employee
$2.23M
$429.29K
Profits Per Employee
$927.45K
-$689.41K
Employee Count
65
74

Income statement (TTM)Industry

Revenue
$144.78M
$66.37M
Gross Profit
$63.22M
$120.78M
Operating Income
$36.65M
-$21.37M
Pretax Income
$69.15M
-$12.95M
Net Income
$60.28M
-$22.35M
EBITDA
$37.81M
-$17.21M
EPS (Diluted)
$0.05
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$34.86M
$17.76M
Net Cash Per Share
$0.03
$0.80
Equity (Book Value)
$122.17M
$53.89M
Book Value Per Share
$0.11
$1.50
Tangible Book Value
$117.37M
$27.13M
Working Capital
$102.59M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
$10.86M
-$12.38M
Capital Expenditures
-$2.15M
-$1.00M
Free Cash Flow
$8.72M
-$18.21M
FCF Per Share
$0.01
-$0.42

Taxes and interestIndustry

Interest Expense
$108.39K
$2.90M
Income Tax
$8.86M
$73.00K
Effective Tax Rate
12.8%
20.9%

Scores and fair valueIndustry

Graham Number
$0.36
$19.34
Piotroski F-Score
7
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodELTPS&P 500DifferenceELTP per yearS&P 500 per year
1 month+1.3%+0.6%+0.7 pts
3 months-35.4%+3.4%−38.8 pts
Year to date-48.9%+13.3%−62.1 pts
1 year-59.2%+16.6%−75.8 pts
3 years+150.8%+86.4%+64.4 pts+35.9%+23.1%
5 years+526.9%+81.9%+445.0 pts+44.4%+12.7%
10 years+79.1%+318.9%−239.7 pts+6.0%+15.4%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M ELTP shares were sold short on Oct 30, 2026, down 1.4% from the previous report. At recent volumes it would take 2.8 days to buy them back.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20262,991,818-1.4%1,084,4602.8
Oct 15, 20263,034,556+15.3%1,738,2691.8
Sep 30, 20262,632,127+1.0%1,177,4432.2
Sep 15, 20262,606,630+2.3%1,685,9081.6
Aug 31, 20262,547,855+1.5%1,880,8021.4
Aug 14, 20262,510,800-6.5%2,006,8531.3
Jul 31, 20262,685,456+3.3%720,4213.7
Jul 15, 20262,599,593-2.1%1,374,7661.9
Jun 30, 20262,654,887+2.3%1,292,9032.0
Jun 15, 20262,594,622-0.2%1,697,9791.5
May 29, 20262,599,516-0.9%801,1383.2
May 15, 20262,622,325+6.0%1,004,4702.6

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?